Clot-Busting treatment may save lives in Moderate-Risk lung clot patients
NCT ID NCT07374978
First seen Feb 01, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study looked at whether giving clot-busting drugs (thrombolysis) to people with moderate-to-high risk lung blood clots and low bleeding risk can reduce deaths within 30 days. Researchers tracked 100 patients to see if the treatment lowered death rates and how often serious bleeding occurred. The goal was to find a safer way to treat dangerous blood clots in the lungs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM SUBACUTE MASSIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, Abbassia, 00202, Egypt
Conditions
Explore the condition pages connected to this study.